Limits of compliance, US Pharmacopeia 42 (% of declared content), and average tablets per month used in sample frame calculations
| API | Assay (%) | Dissolution (Q) (%) | Stage 1 dissolution (Q+5) (%) | Tablets per month |
| Amlodipine | 90–110 | 75 | 80 | 30 |
| Captopril | 90–110 | 80 | 85 | 60 |
| Furosemide | 90–110 | 80 | 85 | 30 |
| Glibenclamide | 90–110 | 70 | 75 | 90 |
| Simvastatin | 90–110 | 75 | 80 | 30 |